'Eisai's Lenvima extends survival period, improves patients’ quality of life'
State organs squandered ₩8.2 billion; failed to spot Invossa problem
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
Foreign patients receiving plastic surgery hit record high in 2018